Iranian Researchers Continue Studies on Application of Cell Therapy Treatment for Coronavirus Patients
TEHRAN (FNA)- Iranian scientists at Celltech Pharmed company, active under the supervision of the Headquarters for Executing the Order of Imam (Khomeini) in Iran, have tested cell therapy to treat 46 patients infected with COVID-19 virus.
“In the initial study, we had 9 patients; also, in one phase of another study, 6 patients and in the second phase, 26 patients were present who went through the experiment,” CEO of Celltech Pharmed company Mohammad Hossein Ziraksaz told FNA on Saturday.
“Of course, we are conducting a national study in which 10 patients were present in the first phase, and stem cells were injected to 5 patients, and it can be said that a sum of 46 patients underwent cell therapy based on medical criteria and standards,” he added, noting that the studies have yielded desirable results.
Ziraksaz said the cell therapy treatment method will be applied to nearly 100 coronavirus patients in the study.
In relevant remarks in September, Managing-Director of the cord blood bank technological company of Royan Institute Morteza Zarrabi said that stem cell therapy of coronavirus patients in Iran has yielded positive results.
“For coronavirus patients, stem cells are injected into the vein twice; before and after the stem cell injection, the patient's condition is thoroughly examined to determine the effect of the stem cells on the lungs, and a CT scan is performed,” Zarrabi told FNA.
"We expect stem cells to modulate the patient's immune cells fighting with coronavirus, repair the lung tissue and prevent impacts of the coronavirus on the lungs," he said.
Zarrabi said that evidence and results that have been obtained so far have shown that using stem cells in the treatment of coronavirus disease can be quite effective and prevent long-term damages, but meantime, stressed that the method needs more examinations.